Aurelia Bioscience is a contract research organisation (CRO) specialising in bioassay development and compound screening. Using cutting- edge technologies to effectively and reliably move novel compounds or biologics through the multiple stages of early drug discovery. Their scientists have decades of experience in pre-clinical discovery, designing and developing low, medium and high throughput assays for pharmacological profiling, hits-to-lead, lead identification and lead optimisation. Clients range from virtual drug discovery organisations through research institutes to mid-large pharmaceutical companies. click here to view their introductory video.